Predict your next investment

HEALTHCARE | Biotechnology

See what CB Insights has to offer


Series A | Alive

About Spree Pharma

Developer of therapeutic indications. The company aims to use Encapsulated Organic Nanoparticle (EON) platform to reformulate a number of compounds.

Spree Pharma Headquarter Location

Østergade 5, 3

Copenhagen, 1100,


45 70 20 12 63

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Spree Pharma

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Spree Pharma is included in 1 Expert Collection, including Nanobiotechnology.



707 items

These companies apply nanotechnology to clinical medicine. They research or develop highly specific, nanoscale interventions to aid in screening, diagnosis, and treatment of biological systems.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.